Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Randall J Bateman, MD
Washington University School of Medicine
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto de Investigaciones Neurologicas Raul Carrea, Fleni
Ciudad Autonoma de Buenos Aire, Argentina
- Neuroscience Research Australia
Randwick, New South Wales, Australia
- Alzheimer'S Research Australia
Melbourne, Victoria, Australia
- Hospital Das Clínicas Da Faculdade de Medicina Da Usp
São Paulo, Brazil
- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Mcgill Center for Studies in Aging
Verdun, Quebec, Canada
- Chu de Quebec - Hôpital de L' Enfant Jésus
Québec, Canada
- Grupo de Neurociencias Sede de la Universidad de Antioquia
Medellín, Colombia
- Chu de Toulouse - Hôpital Purpan
Toulouse, Haute Garonne, France
- Hopital Roger Salengro - Chu Lille
Lille, Nord, France
- Groupe Hospitalier Pitie-Salpetriere
Paris, Paris, France
- Hopital Neurologique Pierre Wertheimer
Bron, Rhone, France
- Chu de Rouen - Hôpital Charles Nicolle
Rouen, Seine Maritime, France
- Universitaetsklinikum Tubingen
Tübingen, Baden-Wurttemberg, Germany
- Lmu-Campus Grosshadern
Munich, Bavaria, Germany
- St Vincent'S University Hospital
Dublin, Ireland
- Irccs Centro San Giovanni Di Dio Fatebenefratelli
Brescia, Italy
- Azienda Ospedaliera Universitaria Careggi
Florence, Italy
- University of Tokyo Hospital
Bunkyō City, Tokyo-To, Japan
- Instituto Nacional de Neurologia Y Neurocirugia Manuel Velasco Suarez
Mexico City, Mexico City, Mexico
- Brain Research Center
Amsterdam, Netherlands
- University of Puerto Rico, School of Medicine
San Juan, Puerto Rico
- Hospital Clínic I Provincial de Barcelona
Barcelona, Spain
- the National Hospital for Neurology and Neurosurgery
London, Greater London, United Kingdom
- University of Alabama in Birmingham
Birmingham, Alabama, United States
- University of California San Diego Medical Center
La Jolla, California, United States
- Usc Keck School of Medicine
Los Angeles, California, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Emory University
Atlanta, Georgia, United States
- Advocate Lutheran General Hospital
Park Ridge, Illinois, United States
- Indiana University School of Medicine
Indianapolis, Indiana, United States
- Washington University in St. Louis
St Louis, Missouri, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Butler Hospital
Providence, Rhode Island, United States
- Kerwin Research Center,
Dallas, Texas, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Dec 2021
- Primary completion
- 30 Apr 2028
- Completion
- 31 Jul 2028
- Last update posted
- 13 Feb 2026
- Registered enrollment
- 197
- Registry id
- NCT05269394
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.